Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.11.18 (
MAP
)
7,412
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The axially chiral ligands 2-(diphenylphosphanyl)-2'-methoxy-1,1'-binaphthalene (MOP; 6) and 2'-dimethylamino-2-(diphenylphosphanyl)-1,1'-binaphthalene (
MAP
; 7) coordinate to a cationic allylpalladium fragment in an unusual bidentate (P,C)-mode through the triarylphosphane and ipso-carbon atom (C1'). The readily prepared
MAP
and MOP complexes [Pd[(P,C)-(L)](n3-allyl)][OTf] (9 (L = 7) and 10 (L = 6)) have been characterised in solution (NMR), in which two diastereoisomeric rotamers are observed. The stereochemical identity of the rotamers is established by one- and two-dimensional NMR spectroscopy experiments. In both the solid state and in solution, the allyl unit is shown to coordinate in a slightly distorted n3-mode that results in a more alkene-like character at the allyl terminus trans to phosphane ligand. The opposite allyl terminus, which is trans to the ipsocarbon atom (C1'), is more strongly bound and the dominant allyl stereodynamic process involves C-C bond rotation in an n'-allyl intermediate bound through this carbon. Palladium complexes of
MAP
and MOP are very efficient catalysts for allylic alkylation of racemic cyclopentenyl pivalate with [NaCH(CO2Me)2] in
THF
. Isotopic desymmetrisation revealed that the reaction occurs with powerful stereochemical memory effects and consequently with low global ee values. The memory effect is suggested to arise through selective generation of diastereoisomeric [Pd[(P,C)-L](n3-cyclopentenyl)]+ ions (L =
MAP
or MOP) and subsequent capture by nucleophile before ion-pair collapse or equilibration occurs.
...
PMID:Diastereoisomeric cationic pi-allylpalladium-(P,C)-MAP and MOP complexes and their relationship to streochemical memory effects in allylic alkylation. 1114 Sep 64
The synthesis and characterization of carboxylate-bridged dimetallic complexes are described. By using m-terphenyl-derived carboxylate ligands, a series of dicobalt(II), dicobalt(III), dinickel(II), and dizinc(II) complexes were synthesized. The compounds are [Co(2)(mu-O(2)CAr(Tol))(2)(O(2)CAr(Tol))(2)L(2)] (1), [Co(2)(mu-OH(2))(2)(mu-O(2)CAr(Tol))(2)(O(2)CAr(Tol))(2)L(2)] (2a-c), [Co(2)(mu-OH)(2)(mu-O(2)CAr(Tol))(2)(O(2)CAr(Tol))(2)L(2)] (3), [Ni(2)(mu-O(2)CAr(Tol))(4)L(2)] (4), [Ni(2)(mu-HO...H)(2)(mu-O(2)CAr(Tol))(2)(O(2)CAr(Tol))(2)L(2)] (5), and [Zn(2)(mu-O(2)CAr(Tol))(2)(O(2)CAr(Tol))(2)L(2)] (6), where Ar(Tol)CO(2)H = 2,6-di(p-tolyl)benzoic acid and L = pyridine,
THF
, or N,N-dibenzylethylenediamine. Structural analysis of these complexes revealed that additional bridging ligands can be readily accommodated within the [M(2)(mu-O(2)CAr(Tol))(2)](2+) core, allowing a wide distribution of M...M distances from 2.5745(6) to 4.0169(9) A. Unprecedented bridging units [M(2)(mu-OH(2))(2)(mu-O(2)CR)(2)](n+) and [M(2)(mu-HO...H)(2)(mu-O(2)CR)(2)](n+) were identified in 2a-c and 5, respectively, in which strong hydrogen bonding accommodates shifts of protons from bridging water molecules toward the dangling oxygen atoms of terminal monodentate carboxylate groups. Such a proton shift along the O...H...O coordinate attenuates the donor ability of the anionic carboxylate ligand, which can translate into increased Lewis acidity at the metal centers. Such double activation of bridging water molecules by a Lewis acidic metal center and a metal-bound general base may facilitate the reactivity of metallohydrolases such as
methionine aminopeptidase
(
MAP
).
...
PMID:Sterically hindered carboxylate ligands support water-bridged dimetallic centers that model features of metallohydrolase active sites. 1182 79